Incidence, medical therapy, and outcomes in heart failure with improved ejection fraction across guideline definitions

Heart Failure

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

Eur J Heart Fail

Ferrannini G, Pol T, Ljungman C, Dahlström U, Merolla A, Lund LH

doi: 10.1093/ejhf/xuag249

Heart Failure

National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

JACC Heart Fail

Keykhaei M, Sandhu AT, Hsue PY, Greene SJ, Ziaeian B, Kittleson M, Villarreal-Gonzalez M, Hallaj S, Ramsis M, Agarwal MA, Fonarow GC

doi: 10.1016/j.jchf.2026.103295

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Heart FailureTherapy and Intervention

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

JACC Cardiovasc Interv

Kobari Y, Maznyczka A, Khokhar AA, Sørensen LM, Lulic D, Bieliauskas G, Raja AA, Ersbøll MK, Rossing K, Gustafsson F, Køber L, Prendergast B, Fosbøl E, De Backer O

doi: 10.1016/j.jcin.2025.10.050

Heart Failure

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

Diabetes Res Clin Pract

Kokura Y, Kishimori T, Kato T, Iwasaki Y, Wada A, Tani A, Yamaji R, Koike J, Matsumoto T, Yagi T, Sekine O, Okada M

doi: 10.1016/j.diabres.2026.113404

Heart Failure

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Eur J Heart Fail

Naser JA, Rahme SJ, Castrichini M, Ibrahim H, Scott CG, Kennedy AM, Eleid MF, Nkomo VT, Foley DA, McKie PM, Borlaug BA, Pislaru SV, Lin G

doi: 10.1093/ejhf/xuag047

Heart Failure

Epidemiology, Clinical Characteristics, and Outcomes for Heart Failure with Improved Ejection Fraction by Chronological Age

ESC Heart Fail

Srikanth K, Lee K, Go AS, Parikh RV, Ambrosy AP, Tan TC, Min K, Hamilton SA, Svetlichnaya J, Solomon SD, Vaduganathan M, Inciardi RM, Vardeny O, Vasti E, Sandhu AT, Ku IA, Adatya S, Bhatt AS

doi: 10.1093/eschf/xvag158

Heart Failure

Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

JACC Heart Fail

Harrington J, Giczewska A, Rao VN, Fudim M, Peters AE, Chrischilles E, Jones WS, May H, Steinberg BA, VanWormer J, Cyr DD, Felker GM

doi: 10.1016/j.jchf.2025.102768

Heart Failure

Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With the Guidelines-Heart Failure Program

Circ Heart Fail

Tang AB, Li S, Li Y, Zhao J, Thomas K, Lewsey SC, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Yancy CW, Fonarow GC

doi: 10.1161/CIRCHEARTFAILURE.125.013835

Related content

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry

National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Epidemiology, Clinical Characteristics, and Outcomes for Heart Failure with Improved Ejection Fraction by Chronological Age

Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With the Guidelines-Heart Failure Program